Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Bank of New York Mellon

Genmab - ADR

PagSeguro Digital

Skyward Specialty Insurance Group Inc

SKWD, PHG, BK, PAGS and GMAB have been added to the Zacks Rank #1 (Strong Buy) List on January 17, 2024.

New Strong Buy Stocks for January 17th

ADMA Biologics

Arcutis Biotherapeutics

OptimizeRx Corp

Phreesia Inc

ADMA, ARQT, PHR, OPRX and PHG have been added to the Zacks Rank #1 (Strong Buy) List on January 11, 2024.

New Strong Buy Stocks for January 11th

AllianceBernstein Hld

Compania Cervecerias Unidas

CCU, AB and PHG made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 11, 2024.

Best Value Stocks to Buy for January 11th

CCU, AB and PHG made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 11, 2024.

Best Income Stocks to Buy for January 11th

Haemonetics

Neogen

Prestige Brands Holdings

Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. PHG, NEOG, HAE and PBH are well-poised to gain from the favorable factors.

4 Medical Product Stocks to Buy Amid Industry Challenges

The U.S. Food and Drug Administration (FDA) on Wednesday classified the recall of Philips' medical imaging devices as most serious as their use could cause serious injuries or death.

US FDA identifies recall of Philips medical imaging devices as most serious

December 19, 2023 Amsterdam, the Netherlands –  Royal Philips  (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 15,134,054 of its shares. The cancelled shares were acquired as part of the EUR 1.5 billion share repurchase program for capital reduction purposes that was announced on July 26, 2021. Philips will complete the share repurchase program in April 2024, which is expected to result in a further cancellation of 4.4 million shares in Q2 2024. Philips' current issued share capital amounts to EUR 182,703,193 representing 913,515,966 common shares.

Philips completes cancellation of 15.1 million shares

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Royal Philips (PHG) is a Top-Ranked Momentum Stock: Should You Buy?

CAMBRIDGE, Mass. & LANSING, Mich.--(BUSINESS WIRE)--Medicaid-eligible Michigan families will now be able to access new and premium content in the Philips Avent Pregnancy+ mobile app, as the Michigan Department of Health and Human Services (MDHHS) has extended its contract with Royal Philips, (NYSE: PHG, AEX: PHIA) a global leader in health technology. Availability of the app, which is funded through Governor Whitmer's Healthy Moms Healthy Babies Initiative, is designed to improve access to care.

Michigan Department of Health and Human Services Expands Philips Avent Pregnancy+ Program; Nearly 80% of Users Say App Has Helped Them Learn More About Locally Available Maternal Health Resources

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, has received a score of 90 out of 100 on the Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index (CEI), the nation's foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality. Philips joins 1,384 major U.S. businesses that were also ranked in the 2023-2024 CEI. The results of the 2023-2024 CEI showcase how U.

Philips Earns High Score for Fifth Time in Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index

Philips (PHG) launches three MR Smart Fit coils, namely TorsoCardiac 1.5T, 1.5T shoulder and Knee 3.0T, enhancing flexibility, reducing patient setup time and improving image quality resolution.

Philips (PHG) Adds Smart Fit Coils to Boost Diagnostic Imaging

The CEO of Exor NV , the largest shareholder in Dutch healthcare equipment maker Philips NV , on Thursday said he continues to believe the company's problems are solvable.

Philips investor Exor: company's problems are "solvable"

Shares in Dutch medical device manufacturer Philips plunged Wednesday after the US Food and Drug Administration warned that its new machine to help patients sleep risked overheating.

Philips stock slumps after new FDA warning

November 29, 2023 Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, and Vanderbilt University Medical Center (VUMC), home to top-ranked adult and pediatric hospitals in the Southeastern U.S., today announced initial results of a research collaboration to decarbonize the health system's radiology department. The project, which was initially announced in May 2023, shows that sustainable initiatives can be both environmentally friendly and cost-effective.

Research from Philips and Vanderbilt shows how decarbonizing healthcare also helps to reduce cost

The FDA warned that Philips Sleep Apnea machines should be closely monitored for signs of overheating.

Philips Stock Falls Nearly 5% After FDA Issues Safety Warning About Its Sleep Apnea Machines

Phillips shares fell sharply Wednesday as the Food and Drug Administration said there's an emerging safety issue involving its product for sleep apnea.

Philips shares slump as FDA says sleep product may overheat

The U.S. Food and Drug Administration said on Tuesday that it is alerting patients about a safety issue with Dutch healthcare technology company Philips' machines used for treatment of obstructive sleep apnea.

US FDA cautions on use of Philips' sleep apnea machines

Philips (PHG) unveils an array of AI-enabled innovations at RSNA23 to enhance diagnostic imaging capabilities across healthcare providers.

Philips (PHG) Bolsters Diagnostic Imaging With New Launches

November 28, 2023 Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today launched three new fit for purpose MR Smart Fit coils at #RSNA23 . RF coils are an essential part of every MRI scan.

Philips launches ultra lightweight and flexible MR Smart Fit coils to improve radiology productivity and diagnostic confidence at #RSNA23

Philips (PHG) showcases BlueSeal MR Mobile to enhance diagnostic imaging capabilities across remote and rural communities.

Philips (PHG) Adds BlueSeal to its Diagnostic Imaging Portfolio

November 27, 2023 Improved imaging and advanced tools drive standardized workflow efficiency across multiple specialties Shared common interface and transducers let users move effortlessly between ultrasound systems for a more simplified user experience  Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today placed workflow and efficiency at the heart of the next generation of its flagship ultrasound systems EPIQ Elite and Affiniti at #RSNA23 . Globally, ultrasound users are challenged with increased patient volume and staffing shortages – exacerbated by more complex cases.

Philips improves workflow and efficiency with next generation ultrasound systems EPIQ Elite and Affiniti at #RSNA23

November 26, 2023 BlueSeal MR Mobile's unique magnet technology advances patient outcomes and access to care with high quality diagnostic imaging and enhanced workflows Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today showcases the world's first mobile MRI system with helium-free operations at #RSNA23 . BlueSeal MR Mobile [1], the industry's first and only 1.5T fully sealed magnet, delivers patient-centric MRI services where and whenever needed.

Philips showcases world's first mobile MRI system with helium-free operations at #RSNA23

November 26, 2023 New innovations help hospitals and health systems to consistently deliver accessible, high-quality care to patients in a sustainable way Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today puts patients and healthcare providers center-stage at #RSNA23 , the world's largest medical imaging conference. Radiologists are looking for solutions to improve the performance of their departments and help patients with optimized workflows, shorter procedure times and user-friendly operations.

Philips launches new-AI enabled innovations at #RSNA23 that free up healthcare providers to focus on patient care

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Royal Philips (PHG) is a Strong Growth Stock

November 16, 2023 To unlock patient data for precision diagnosis and treatment, the new partnership includes digital pathology, clinical informatics, and innovative AI-enabled diagnostics with an enterprise monitoring as a service model New York, NY –  Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, and NYU Langone Health, the nation's top-ranked academic medical center, [1] today announced an 8-year strategic partnership valued up to USD 115 million and aimed at enhancing patient care through further innovation. With the new technologies, NYU Langone clinicians can collaborate in real-time, whether sharing pathology, imaging studies or patient data to support diagnostic confidence and tailor individualized care plans.

News for Royal Philips Stock (PHG)